120
Participants
Start Date
November 8, 2016
Primary Completion Date
July 20, 2021
Study Completion Date
July 20, 2021
Talazoparib
Maximum starting dose: 1mg/day or last tolerated dose in the originating protocol
Magyar Honvedseg Egeszsegugyi Kozpont, Onkologiai Osztaly, Budapest
Institut Paoli-Calmettes, Marseille
Orlando Health, Inc., Orlando
Memorial Hospital West, Pembroke Pines
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Investigational Drug Senvices, Indianapolis
IU Health University Hospital, Indianapolis
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
IU Health Bloomington Hospital, Bloomington
University of Michigan Health System, Ann Arbor
Karmanos Cancer Institute, Detroit
The University of Texas MD Anderson Cancer Center, Houston
(IRB# 16-001189) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
TRIO-US Central Administration, Los Angeles
UCLA Hematology/Oncology, Los Angeles
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles
UCLA Hematology/Oncology - Santa Monica, Santa Monica
UCLA Torrance Oncology, Torrance
Frauenklinik des Universitaetsklinikums Erlangen, Erlangen
UCLA Hematology/Oncology - Pasadena, Pasadena
UCLA Hematology/Oncology - Porter Ranch, Porter Ranch
UCLA Hematology/Oncology - Santa Clarita, Valencia
UCLA Hematology/Oncology - Burbank, Burbank
UCLA Hematology/Oncology - Alhambra, Alhambra
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield
"FSBEI HE First Moscow State Medical University n.a. I.M. Sechenov of the MoH of the RF", Moscow
Medical Technologies LLC, Saint Petersburg
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles
Rutgers Cancer Institute of New Jersey, New Brunswick
Cross Cancer Institute, Edmonton
Juravinski Cancer Clinic, Hamilton
Jewish General Hospital, Montreal
"Orszagos Onkologiai Intezet B Belgyogyaszati-Onkologiai Osztaly es Klinikai Farmakologiai Osztaly", Budapest
Arensia Exploratory Medicine, Institutia Medico-Sanitara Publica Institutul Oncologic, Chisinau
Szpital Lux Med, Warsaw
Royal Marsden NHS Foundation Trust, Sutton
Lead Sponsor
Collaborators (1)
Medivation, Inc.
INDUSTRY
Pfizer
INDUSTRY